(Press-News.org) To understand the health effects of high cholesterol levels, doctors first need to assess malnutrition and inflammation status in their chronic kidney disease (CKD) patients, according to a study appearing in an upcoming issue of the Journal of the American Society Nephrology (JASN).
Patients with CKD often develop and die from cardiovascular disease (CVD). While it's well known that high cholesterol puts people at risk for CVD in the general population, the relationship is not so clear in CKD patients. In fact, research has shown that dialysis patients with higher cholesterol levels die at a lower rate than those with lower cholesterol levels. It's not that high cholesterol is beneficial; rather, it may indicate a lesser degree of malnutrition and inflammation, two serious and interrelated complications of kidney disease.
To see whether malnutrition and/or inflammation might modify the relationship of cholesterol and CVD, Gabriel Contreras MD MPH (University of Miami Miller School of Medicine), senior author Lawrence Appel, MD (Welch Center for Prevention, Epidemiology and Prevention, Johns Hopkins Medical Institutions), and colleagues studied 990 African-Americans with hypertension and CKD who were not yet on dialysis, 31% of whom had malnutrition and/or inflammation. Over the course of 12 years, 20% of patients experienced a new CVD event such as heart attack, stroke, congestive heart failure, or death from heart disease, with similar numbers in the groups with (19%) and without malnutrition and/or inflammation (21%). In the patients with malnutrition and/or inflammation, high blood cholesterol levels were not associated with CVD events; however, in the patients without malnutrition and/or inflammation (69%), patients' risk of developing a new CVD event increased as cholesterol levels rose. (Compared to patients with cholesterol levels less than 200 mg/dL, patients with cholesterol levels between 200 and 239 mg/dL had a 1.19-fold increased risk; those with cholesterol levels of 240 mg/dL or more had a 2.18-fold increased risk.)
Take-away message: "In CKD patients, the inconsistent and often inverse relationship of cholesterol level with CVD and overall mortality may be explained by the presence of malnutrition and/or inflammation," said Dr. Contreras. "Whereas traditional risk factors such as elevated blood cholesterol levels remain important, they appear to compete and interact with non-traditional risk factors such as malnutrition and inflammation. Doctors caring for CKD patients should take into account the presence of malnutrition and inflammation as they interpret blood cholesterol levels." Malnutrition and/or inflammation complicate blood cholesterol readings in CKD patients, making it important that physicians investigate the causes of high or low cholesterol in their patients.
###
The National Institute of Health of the African American Study of Kidney Disease and Hypertension sponsored the study. Study co-authors include Bo Hu, PhD, Cynthia Kendrick, Jennifer Gassman, PhD (Cleveland Clinic Foundation); Brad Astor, PhD (Welch Center for Prevention, Epidemiology and Prevention, Johns Hopkins Medical Institutions); Tom Greene, PhD (University of Utah); Thomas Erlinger, MD (Seton Hospital); John Kusek, PhD (National Institute of Diabetes and Kidney Diseases); Michael Lipkowitz, MD (Mount Sinai School of Medicine); Julia Lewis, MD (Vanderbilt University); Otelio Randall, MD (Howard University); Lee Hebert, MD (Ohio State University); Jackson Wright, Jr, MD, PhD (Case Western Reserve University); George Bakris, MD (University of Chicago Pritzker School of Medicine); and Joel Kopple, MD (Harbor UCLA Medical Center, the David Geffen School of Medicine at UCLA and the UCLA School of Public Health) for the African-American Study of Kidney Disease and Hypertension Study Group.
Disclosures: The authors reported no financial disclosures.
The article, entitled "Malnutrition-Inflammation Modifies the Relationship of Cholesterol with Cardiovascular Disease," will appear online at http://jasn.asnjournals.org/ on September 23, 2010, doi 10.1681/ASN.2009121285.
The content of this article does not reflect the views or opinions of The American Society of Nephrology (ASN). Responsibility for the information and views expressed therein lies entirely with the author(s). ASN does not offer medical advice. All content in ASN publications is for informational purposes only, and is not intended to cover all possible uses, directions, precautions, drug interactions, or adverse effects. This content should not be used during a medical emergency or for the diagnosis or treatment of any medical condition. Please consult your doctor or other qualified health care provider if you have any questions about a medical condition, or before taking any drug, changing your diet or commencing or discontinuing any course of treatment. Do not ignore or delay obtaining professional medical advice because of information accessed through ASN. Call 911 or your doctor for all medical emergencies.
Founded in 1966, the American Society of Nephrology (ASN) is the world's largest professional society devoted to the study of kidney disease. Comprised of 11,000 physicians and scientists, ASN continues to promote expert patient care, to advance medical research, and to educate the renal community. ASN also informs policymakers about issues of importance to kidney doctors and their patients. ASN funds research, and through its world-renowned meetings and first-class publications, disseminates information and educational tools that empower physicians.
END
STANFORD, Calif. - A simple, inexpensive blood test could soon help doctors halt organ rejection before it impairs transplanted hearts and kidneys.
"In the past, we couldn't spot rejection episodes until they harmed the organ," said Atul Butte, MD, PhD, who is co-senior author of the new research and an associate professor of medical informatics and of pediatrics at the Stanford University School of Medicine, in addition to director of the Center for Pediatric Bioinformatics at Lucile Packard Children's Hospital. "Our goal is to develop blood tests that will keep transplanted ...
Researchers have identified a gene that appears to increase a person's risk of developing late-onset Alzheimer disease (AD), the most common type of the disease. Abbreviated MTHFD1L, a gene on chromosome six, was identified in a genome-wide association study by a team of researchers led by Margaret Pericak-Vance, Ph.D., director of the John P. Hussman Institute for Human Genomics (HIHG) at the University of Miami Miller School of Medicine. Details appear September 23 in the open-access journal PLoS Genetics.
The World Health Organization estimates that there are currently ...
PRINCETON, N.J. (September 23, 2010) — Increasing the costs to consumers of beer, wine, and hard liquor significantly reduces the rates of a wide range of alcohol-related deaths, diseases, injuries, and other problems, according to a new study published in today's online edition of the American Journal of Public Health and scheduled for inclusion in the November print edition. Researchers at the University of Florida (UF) report that public policies that increase the price of alcoholic beverages, such as increases in alcohol excise taxes, not only reduce drinking but also ...
Engineering researchers from Tufts University, the University of Wisconsin-Madison and Harvard University have demonstrated the low-temperature efficacy of an atomically dispersed platinum catalyst, which could be suitable for on-board hydrogen production in fuel-cell-powered vehicles of the future.
An alternative to copper, which under certain conditions can ignite spontaneously, the platinum-based catalyst is highly active and stable. The researchers' understanding of the structure and function of the new catalyst could help manufacturers design highly effective—but ...
Breast cancer incidence declined among postmenopausal women in Canada as their use of hormone therapy declined, according to a study published online September 23 in The Journal of the National Cancer Institute.
The Women's Health Initiative (WHI) trial of more than 16,000 postmenopausal women in the United States reported in 2002 that the risks of combined estrogen and progestin hormone replacement therapy outweighed the benefits. As a result, prescriptions for hormone therapy fell dramatically in several countries around the world and so did the incidence of breast ...
Researchers in Germany have gained new insight into how the immune system causes damage associated with multiple sclerosis (MS), an incurable neuroinflammatory disorder. Using imaging tools which enable investigation of processes in living organisms, they were able to show a direct interaction between immune cells and neurons which plays a significant role in neuronal injury. However, this direct interaction may respond to therapeutic intervention. The study by Dr. Volker Siffrin and Professor Dr. Frauke Zipp (formerly Max Delbrück Center for Molecular Medicine, MDC, Berlin-Buch, ...
Los Angeles, CA (Sept 23, 2010) Divisive primaries may waste precious campaign resources and damage the primary winner's reputation and chances to win the general election, according to a study in the current American Politics Research (published by SAGE). The timing of the primary in proximity to the general election can also play a role in the results.
To test the effects of divisive primary battles on general election outcomes, researchers gathered primary and general election vote data for all incumbent House races between 1972 and 1998 in which both parties held ...
Researchers at UCLA's Jonsson Comprehensive Cancer Center have discovered a new cell signaling pathway that controls cell growth and development, a pathway that, when defective, helps promote the formation of several major forms of human cancer, including lymphoma and leukemia.
The new pathway, part of a global DNA damage response, turns off 136 genes, including some that have are known to cause cancer because, unchecked, they can promote aberrant cell division.
"It's important to make sure this pathway works correctly, because it prevents cells from dividing excessively" ...
The Office of Naval Research Global (ONR Global) continues to pursue aggressive energy goals established by Secretary of the Navy Ray Mabus, with the design of a system that controls electrical flow for lighting, a highly efficient platform that may spark a new era of power savings.
Designed by the Tokyo Institute of Technology and fine-tuned by researchers at MERSTech in partnership with the ONR Global's office in Tokyo, the Magnetic Energy Recovery Switch (MERS) harnesses and recycles residual magnetic power that is produced by electrical current. By using a device ...
Scientists at the Institute for Research in Biomedicine (IRB Barcelona) headed by the coordinator of the Structural and Computational Biology Programme, Miquel Coll, have published a new study that demonstrates that raltegravir, the drug approved in 2007 for the treatment of AIDS that is sold by Merck under the name Isentress, cancels the function of an essential protein for the replication of one kind of herpes virus. This study, published in the journal Proceedings of the National Academy of Sciences (PNAS), is the first step towards the development of a drug against ...
